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Abstract
Background: To complement next-generation sequencing technologies, there is a pressing need for efficient pre-
sequencing capture methods with reduced costs and DNA requirement. The Alu family of short interspersed
nucleotide elements is the most abundant type of transposable elements in the human genome and a recognized
source of genome instability. With over one million Alu elements distributed throughout the genome, they are
well positioned to facilitate genome-wide sequence amplification and capture of regions likely to harbor genetic
variation hotspots of biological relevance.
Results: Here we report on the use of inter-Alu PCR with an enhanced range of amplicons in conjunction with
next-generation sequencing to generate an Alu-anchored scan, or ‘AluScan’, of DNA sequences between Alu
transposons, where Alu consensus sequence-based ‘H-type’ PCR primers that elongate outward from the head of
an Alu element are combined with ‘T-type’ primers elongating from the poly-A containing tail to achieve huge
amplicon range. To illustrate the method, glioma DNA was compared with white blood cell control DNA of the
same patient by means of AluScan. The over 10 Mb sequences obtained, derived from more than 8,000 genes
spread over all the chromosomes, revealed a highly reproducible capture of genomic sequences enriched in genic
sequences and cancer candidate gene regions. Requiring only sub-micrograms of sample DNA, the power of
AluScan as a discovery tool for genetic variations was demonstrated by the identification of 357 instances of loss
of heterozygosity, 341 somatic indels, 274 somatic SNVs, and seven potential somatic SNV hotspots between
control and glioma DNA.
Conclusions: AluScan, implemented with just a small number of H-type and T-type inter-Alu PCR primers, provides
an effective capture of a diversity of genome-wide sequences for analysis. The method, by enabling an
examination of gene-enriched regions containing exons, introns, and intergenic sequences with modest capture
and sequencing costs, computation workload and DNA sample requirement is particularly well suited for
accelerating the discovery of somatic mutations, as well as analysis of disease-predisposing germline
polymorphisms, by making possible the comparative genome-wide scanning of DNA sequences from large human
cohorts.
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Background
Next-generation, massively-parallel sequencing technolo-
gies have transformed the landscape of genetics through
their ability to produce giga-bases of sequence informa-
tion in a single run. However, the sequencing cost, com-
putation workload and amount of sample DNA required
are still too high for large scale population analysis by
means of whole-genome sequencing. There is clearly a
need for pre-sequencing capture of subsets of the gen-
ome in order to reduce these requirements. Although
the whole exome represents a valuable subset, its exclu-
sion of introns, and the high cost and high DNA
requirement for its analysis, remain major limitations.
Other sequence subsets therefore clearly need to be
explored.
Alu-transposons are a family of primate-specific short
interspersed nucleotide elements (SINE) of ~ 300 bp
derived from 7SL RNA [1]. Although Alu elements were
once considered as ‘junk DNA’, their biological impor-
tance, in particular their influence on genome instability
is being increasingly recognized [2,3]. They are abun-
dant in gene-rich regions [4,5], exert a major impact on
genomic architecture [6], and increase local recombina-
tion rates [7]. Previously we have found enhanced SNP
frequencies in the vicinity of Alu-elements [8], more so
among the youngest AluY elements than the intermedi-
ate-age AluS and the oldest AluJ. AluYs display also a
higher rate of methylation, consistent with a stronger
silencing pressure on these elements [9]. Genotypic var-
iations surrounding a human lineage-specific AluY
insertion in the GABRB2 gene encoding GABAA recep-
tor b2 subunit have been found by us to constitute a
joint focal point for positive evolutionary selection [10],
hotspot recombinations [11] as well as association with
schizophrenia and bipolar disorder [12,13]. Neighbor-
hoods of Alu-transposons are therefore a highly signifi-
cant sequence subset of the human genome in terms of
evolutionary development and pathogenesis.
Inter-Alu PCR is a useful method for isolating human
DNA in the presence of animal DNA [14], linkage map-
ping [15], creation of human specific probes and finger-
prints [16], and detection of mutator phenotypes [17] or
high frequency genetic alterations [18]. The general
strategy of the method is to employ a single PCR primer
based on the Alu consensus sequence to amplify the
sequence between two Alu elements. With well over a
million Alu-transposons in the human genome, the
average distance between two Alus is only 2.4 kb (Figure
1A), which suggests that inter-Alu PCR with an
enhanced amplicon range coupled to next-generation
sequencing could yield a huge sequence subset of the
human genome for analysis. Accordingly the objective
of the present study is to examine the possibility of
enhancing the amplicon range of inter-Alu PCR and
combining it with next generation sequencing to scan
for sequence and structure variations in the human
genome.
Results
Individual Alu-transposons in the human genome are
on the average only 15 - 20% divergent from each other,
and PCR primers complementary to the Alu consensus
Figure 1 Inter-Alu sequences in the human genome. (A) Length
distribution of inter-Alu distances between two adjacent Alu-
transposons in the reference human genome. Heights of bars
represent number of adjacent Alu pairs in the human genome at
different inter-Alu distances. Subtraction of empty column at < 200
bp representing short inter-Alu sequences that were removed from
analysis during library construction for next generation sequencing
leaves the solid columns of inter-Alu sequences of varying lengths
capturable from the genome. The total sum of the solid columns
up to an inter-Alu distance of 6 kb, 8 kb or 10 kb equals 1.10 Gb,
1.36 Gb or 1.58 Gb, respectively. (B) Inter-Alu sequences of 0.2-6.0 kb
in length that are in principle capturable by the three Alu-
consensual primers AluY278T18, AluY66H21 and R12A/267. Such
capturable amplicons amount to ~14 Mb if no mismatch is allowed
between the consensual primers and template sequences, or ~106
Mb if one mismatch is allowed per primer. The graph shows the
length distribution of the latter 106 Mb.
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sequence have been employed for inter-Alu PCR
[14-18]. Likewise PCR primers based on consensus
sequences in the AluJ, AluS and AluY subfamilies could
also be devised. All Alu-based primers can be divided
into ‘H-type’ where the primer extends outward from
the head of the Alu, or ‘T-type’ where it extends out-
ward from the poly-A containing tail. Previously, single
general Alu consensus primers had given rise to agarose
gel electrophoretograms displaying largely banded,
banded plus smeared, or largely smeared patterns
[14-18]. In the present study, varying combinations of
Alu, AluJ, AluS and/or AluY consensus primers were
found to yield widely different electrophoretogram pat-
terns. The presence of a single H-type or T-type primer
tended to yield a banded, non-smeared pattern sugges-
tive of a limited amplicon range (lanes A-D, Figure 2).
In lanes I and L respectively, even two or three T-type
primers failed to give a non-banded pattern; lane K with
three H-type primers gave a smeared pattern but lane F
with two H-type primers gave only a banded pattern. In
contrast, various primer combinations containing both
H-type and T-type primers, allowing the amplification
of intervening sequences between two Alu heads,
between two Alu-tails as well as between one head and
one tail, readily yielded a smeared gel indicating the pre-
sence of a wide diversity of amplicons of different sizes
(lanes E, G, H, J, P-V). Therefore inclusion of both H-
type and T-type primers provided the most reliable
method for achieving huge amplicon range using no
more than a small number of primers. The greater
staining intensity of lane S compared to lane R further
showed that the amounts of amplicons obtained from
the same primer set could be increased by increasing
the primer concentrations.
When AluScans were performed on paired control
and cancer DNAs extracted from respectively the white
blood cells and glioma tissue of a male Han Chinese
patient using the three primers AluY278T18,
AluY66H21 and R12A/267 described under Methods,
smeared gels of amplicons up to ~ 6 kb in size were
obtained (Figure 2, lane Q for control DNA). In each
case the use of 90 ng sample DNA yielded sufficient
amplicons for next-generation sequencing on the Illu-
mina platform with a single flowcell lane and 75 bp
paired-end reads. The sequencing output has been sub-
mitted to Sequence Read Archive (SRA) of NCBI. As
indicated in Table 1, 837 Mb of the initial reads of con-
trol white blood cell DNA were mapped using the BWA
program [19] to 58.9 Mb regions on the reference
human genome (GRCh37.p2), including high quality
mapping of 717 Mb reads to 10.6 Mb regions with mini-
mum 10 times and average 67 times coverage. Of the
latter 10.6 Mb, 95% were inter-Alu sequences, which
compared favorably with the NimbleGen SeqCap Exome
array for targeted exon capture with typically 71%
mapped reads on target [20]; 53% were genic sequences
including both exons and introns from 8,502 genes,
representing an enrichment of genic sequences com-
pared to the overall 40% gene content of the human
genome; and 34% of the genes belonged to the list of
Figure 2 Amplicon range of inter-Alu PCR. The different lanes show gel electrophoretograms of amplicons obtained using different single
primer or multiple primer sets: (A) AluJo56H16 alone; (B) AluJo232T16 alone; (C) AluSq56H16 alone; (D) AluSq263T16 alone; (E) AluJo56H16 and
AluJo232T16; (F) AluJo56H16 and AluSq56H16; (G) AluJo56H16 and AluSq263T16; (H) AluJo232T16 and AluSq56H16; (I) AluJo232T16 and
AluSq263T16; (J) AluSq56H16 and AluSq263T16; (K) AluJo56H16, AluSq56H16 and H-type L12A/8; (L) AluJo232T16, AluSq263T16 and T-type R12A/
267, (N) AluY278T18, (P) AluY278T18 and AluY66H21, (Q)-(S) AluY278T18, AluY66H21 and R12A/267, (T) AluJo56H16, AluSq56H16 and
AluSq263T16, (U) AluJo56H16, AluSq263T16 and AluJo232T16, (V) AluJo56H16, AluSq263T16 and L12A/8, and (M) M.W. markers. Notably, lanes E,
G, H, J, P-V, where the inter-Alu PCR was performed using both H-type and T-type primers, gave rise to a largely smeared gel. Comparison of
lanes N and P showed the conversion of a banded pattern obtained using a single T-type primer to a smeared one through the addition of an
H-type primer. The much stronger staining intensity of lane S relative to lane R showed that the 0.30 μM concentrations of the same three
primers in S compared to 0.10 μM in R resulted in increased amounts of amplicons. The primers AluJo56H16 (5’-GGCTCAAGCGATCCTC-3’),
AluJo232T16 (5’-TATGATCGTGCCACTG-3’), AluSq56H16 (5’ACCTCAGGTGATCCAC-3’), and AluSq263T16 (5’-AACAAGAGCGAAACTC-3’) were based on
AluJo and AluSq consensus sequences [20]. H-type L12A/8 was an Alu consensus primer suggested earlier for inter-Alu PCR [15]. AluY278T18,
AluY66H21 and T-type R12A/67 are described in Methods.
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cancer candidate genes in Gene Ranker: TCGA GBM
6000, exceeding the 26% of all human genes included in
that list. The genomic regions mapped by the reads fol-
lowed closely the number of Alu transposons located on
the chromosomes (Figure 3). With glioma DNA, 984
Mb of the initial reads were mapped to 64.3 Mb geno-
mic regions, including 11.8 Mb high quality regions
with minimum 10 times and average 72 times coverage.
The overlap between the high quality regions mapped
by the control- and glioma-reads totalled 9.5 Mb, equal
to 90% of the control-mapped regions; the correlation in
read coverage between control and glioma reads was
high, with r = 0.958; the density distributions of the
control and glioma reads along different chromosomes
(Figure 4) were also highly correlated, with r = 0.957.
These results provided evidence that AluScan performed
with the same set of primers enabled a reproducible
genome-wide capture of DNA sequences that were
enriched in both genic content and cancer candidate
genes despite the many overlapping inter-Alu amplicons
that might be amplified by a mixture of H- and T-type
primers.
Figure 5 and Additional File 1 show the distributions
of genetic variations occurring in the 10.6 Mb control
genomic sequences relative to reference human genome
among different chromosomes and types of genomic
regions: there were 18,506 germline SNVs, 11,039 or
59.6% of which were novel SNVs absent from
dbSNP132, 2,108 small (≤ 30 bp) indels and two larger
indels, viz. a 75-bp deletion on chromosome 19 and a
767-bp deletion on chromosome 3. When 60 SNV-con-
taining genic segments including 10 segments each con-
taining a novel SNV were randomly chosen from the
control AluScan output for Sanger sequencing, the accu-
racy of successful SNV verification was 81.6%.
Comparison of the mapped control and glioma
sequences identified 274 somatic SNVs between them,
70.4% of which represented novel SNVs absent from
dbSNP132. In the control and glioma SNVs relative to
the reference human genome, as well as the somatic
SNVs occurring between control and glioma, transitions
were far more numerous than transversions (Additional
File 2). There were 357 instances of loss of heterozygosity
Table 1 Control and glioma sequence outputs from AluScan
Control Glioma
Total initial reads (bp) 896,661,780 1,065,234,324
Initial reads (bp) mapped to GRCh37.p2 836,745,196 983,798,813
Genomic regions mapped (bp) with coverage ≥ 1 58,876,070 64,297,421
Reads mapped (bp) with coverage ≥ 10 717,228,580 853,715,563
Genomic regions mapped with coverage ≥ 10:
Total regions (bp) 10,638,683 11,846,868
Average depth (x) 67.4 72.1
Inter-Alu sequences mapped (bp) 10,149,445 11,275,690
Genic sequences mapped (bp) 5,644,023 6,274,433
Genic sequences mapped as % of total mapped regions 53.1% 53.0%
Excess in genic sequencesa 13.1% 13.0%
Number of genes with mapped region 8,502 9,205
Number of cancer candidate genesb with mapped region 2,921 3,096
Cancer candidate genesb with mapped region as
% of genes with mapped region
34.4% 33.6%
Excess in cancer candidate genesc 8.4% 7.6%
aExcess in % genic sequences with mapped region relative to the 40% genic sequences in the reference human genome.
bCancer candidate genes refer to genes listed in Gene Ranker: TCGA GBM 6000.
cExcess in % cancer candidate genes with mapped region relative to the 26% of total human genes included in Gene Ranker: TCGA GBM 6000.
Figure 3 Correlation between number of Alu elements and
sequences captured. Relationship between the number of Alu
elements occurring on individual human chromosomes (blue bars)
and the amount of AluScan-captured sequences of white blood cell
DNA mapped to the different chromosomes (red triangles).
Correlation coefficient was 0.939 between these quantities.
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(LOH) and 341 somatic indels between control and
glioma DNAs. The LOHs were unequally distributed
among different chromosomes (Additional File 3). Of the
four particularly LOH-enriched regions, viz. regions 1p,
9p, 9q and 19q indicated in Figure 6, notably 1p and 19q
were known to contain glioma-associated deletions [21],
which furnished valuable cross validation between AluS-
can and other genomic approaches.
Seven 5-Mb intervals in the glioma sequences displayed
enhanced numbers of somatic SNVs, where the number
of somatic SNVs > 4, indicating the potential presence
of somatic SNV hotspots (Figure 6). Of these seven
potential SNV hotspots, those in chromosomal regions
12q13, 17q21, 18p11, 19p13 and 19q13 harboured alto-
gether 16 SNV-containing genes including RAB5C of
the RAS oncogene family in 17q21 (Additional File 4).
None of these 16 genes were included in OMIM as a
known glioma-associated gene. These findings illustrated
the usefulness of AluScan as a discovery tool.
Discussion
Using only 90 ng sample DNA in each instance, the
AluScans performed in the present study with one H-
type and two T-type primers generated reads that cov-
ered a total of ~58-64 Mb, or ~1.9-2.1% of genomic
sequences. This total was comparable in order of magni-
tude to the genomic sequences in principle capturable
by the set of three H and T-type consensual Alu-based
primers employed, which were estimated to be ~14 Mb
for exact primer-template matches, or ~106 Mb allow-
ing for one mismatched base-pair per primer (Figure
1B), but still far below the total of 1.10 Gb inter-Alu
regions of ≤ 6 kb in length in the human genome (Fig-
ure 1A). Thus there could be ample room for widening
the scope of AluScan-capturable sequences through the
use of diverse combinations of H- and T-type primers.
Primers specific for other transposable elements such as
LINEs, LTRs, as well as other types of more specialized
primers could also be utilized to tailor the AluScan cap-
ture to a given investigational goal. Moreover, by treat-
ing target DNA with bisulfite to modify unmethylated
C-residues prior to AluScan, epigenomic changes in
normal and diseased cells may also be monitored.
By combining the twin advantages of multitudinous
amplification of inter-Alu sequences through the joint
usage of H-type and T-type primers, and massively par-
allel next-generation sequencing, AluScan thus provides
a new method for genome-wide investigation in addition
to whole genome sequencing (WGS) and whole exome
sequencing (WES). WGS is the standard in comprehen-
siveness, but incurs high operation cost, large computa-
tion workload and multi-microgram DNA requirement.
WES provides integral insight into the entire exome, but
leaves the intronic regions uncharacterized, besides
incurring high capture cost and multi-microgram DNA
requirement. AluScan permits an examination of gene-
enriched segments of exons, introns and intergenic
sequences requiring comparatively modest capture and
sequencing costs, lighter computation workload and
only sub-microgram DNA samples. These three meth-
ods complement one another, together making possible
a comprehensive analysis of sequence and structure var-
iations of the human genome.
Conclusions
AluScan implemented with just a small number of PCR
primers based on consensus Alu sequences provides a
multiplex method for genome-wide sequence analysis.
Through the inclusion of H and T type primers, the
approach employs the abundance and wide distribution
of Alu elements in the human genome as the basis for
the effective capture of a huge number of DNA
sequences in the vicinity of Alu elements. As demon-
strated by the strong correlation between the captured
white blood cell and glioma sequences, the same set of
H and T-type primers has led to an extensively reprodu-
cible subset of genomic sequences in the two separate
Figure 4 Density distributions of captured sequences mapped
on chromosomes. The lengths of genomic sequences (blue or red
peaks) mapped within 10-kb non-overlapping windows were
plotted along chromosomes 1-22, X and Y using Human Genome
Graphs (http://genome.ucsc.edu/cgi-bin/hgGenome) for (A) white
blood cell DNA and (B) glioma DNA.
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AluScans. As well, at least for this set of H and T-type
primers, the captured sequences were enriched in genic
and cancer-related DNA sequences.
The results in Figure 6 illustrate the utility of AluScan
as a discovery tool. Comparison of the paired while blood
cell-glioma DNAs of a single patient has led to the unco-
vering of 357 LOHs and 274 somatic SNVs, a majority of
which likely arising in the glioma, and seven potential
SNV hotspots located on six different chromosomes.
Importantly, the modest technical cost and DNA sample
size required for AluScan will render practicable a follow
up with similarly paired AluScans for tens to hundreds of
glioma patients in order to distinguish the somatic and
germline driver mutations fundamental to the develop-
ment of the disease from passenger mutations. A major
application of AluScan will thus reside in its facilitation
of large cohort studies for clinical and biological investi-
gations of the human genome.
Figure 5 Genetic variations identified in the white blood cell genome relative to the reference human genome. From the outside, Tracks
1 and 2: numbering and cytobands of different chromosomes. Track 3: red dots showing number of SNVs per 1 Mb window (scale: 0-60, 1 div =
12). Track 4: blue dots showing number of indels of ≤ 30 bp per 1 Mb window (scale: 0-12, 1 div = 2.4). Inner circle: green bars showing
positions of structural variations in the form of two large indels at chromosomes 3 and 19. The figure was drawn using the Circos program [29].
Mei et al. BMC Genomics 2011, 12:564
http://www.biomedcentral.com/1471-2164/12/564
Page 6 of 9
Methods
DNA samples
Paired blood and cancer samples were obtained with
consent and institutional ethics approval from a male
Chinese Han patient with anaplastic oligodendroglioma
at Beijing Tiantan Hospital for the preparation of con-
trol DNA by phenol-chloroform extraction and cancer
genomic DNA using the AllPrep kit (Qiagen).
Inter-Alu PCR and next-generation sequencing
Fifteen parallel 25-μl PCR reaction mixtures each con-
taining 2 μl Bioline 10× NH4 buffer (160 mM ammo-
nium sulfate, 670 mM Tris-HCl, pH 8.8, 0.1% stabilizer),
3 mM MgCl2, 0.15 mM dNTP mix, 0.3 μM
AluY278T18 primer, 0.18 μM AluY66H21 primer, 0.06
μM R12A/267 primer, 1 unit Bioline Taq polymerase,
and 6 ng control or glioma DNA. PCR amplification for
Figure 6 Somatic mutations in glioma cells. From the outsider, Tracks 1 and 2: numbering and cytobands of different chromosomes. Track 3:
black bars showing the LOH-enriched loci in chromosomal regions, most prominently in 1p, 9p, 9q and 19q. Track 4: blue bars showing number
of somatic indels of ≤ 30 bp per 5-Mb window (scale: 0-6). Track 5: red bars showing number of somatic SNVs per 5-Mb window (scale: 0-8). The
cytogenetic locations of seven potential SNV hotspots displaying a density of somatic SNVs > 4, viz. greater than the sum of the Mean (= 1.5)
plus two-times the standard deviation (= 1.9), per 5-Mb window are indicated as 11q13.4, 12q13, 16p13.1 etc.
Mei et al. BMC Genomics 2011, 12:564
http://www.biomedcentral.com/1471-2164/12/564
Page 7 of 9
AluScan included DNA denaturation at 95°C for 5 min,
followed by 35 cycles each of 30 s at 95°C, 30 s at 54°C,
and 5 min at 71°C, and finally another 5 min at 71°C.
Amplicons were purified with ethanol precipitation, and
≥ 3 μg purified products per sample were employed for
Illumina GAII library construction and sequencing at
Beijing Genomics Institute (Shenzhen, China).
AluY278T18 (5’-GAGCGAGACTCCGTCTCA-3’),
where ‘AluY’ represents the subfamily, ‘278’ the first
position on the AluY consensus sequence paired with
the primer, ‘T’ a ‘Tail-type’ primer (vs. ‘H’ for ‘H-type’),
and ‘18’ the length of the primer, and AluY66H21 (5’-
TGGTCTCGATCTCCTGACCTC-3’) were AluY con-
sensus primers [22,23]. R12A/267 (T-type) was an Alu
consensus primer employed earlier for inter-Alu PCR at
an annealing temperature of 56°C [18].
Agarose gel electrophoresis
PCR was performed basically as described in the preced-
ing section, except that one PCR tube of 20 μl contain-
ing 100 ng control DNA was employed. The annealing
temperatures were chosen to maximize in each instance
the yield of amplicons: 60°C for lane A in Figure 2, 58°C
for B-D, 56°C for H and L, 64°C for N, and 54°C for the
other lanes. Primer concentration was 0.30 μM for the
single-primer lanes A-D; 0.15 μM per primer for the
two-primer lanes E-J; 0.10 μM per primer for the three-
primer lanes K, L, R, T-V; 0.30 μM per primer for the
triple-dosed lane S. The concentrations of primers
AluY278T18, AluY66H21 and R12A/267 in lane Q were
0.375 μM, 0.225 μM, 0.075 μM respectively; lane P was
same as lane Q with omission of R12A/267; and lane N
was same as lane P with further omission of
AluY66H21.
Read mapping and variant analysis
Sequence reads were mapped to the GRCh37.p2 refer-
ence human genome using BWA (bwa-short algorithm
version 0.5.9rc1) with default settings [19]. Initial map-
ping results were transferred into indexed and sorted
BAM format using SAMtools version 0.1.12a [24], and
further recalibrated and locally realigned using the Gen-
ome Analysis Toolkit (GATK version 1.0.4905) software
[25]. Regions with read depths of < 10× were not ana-
lyzed further.
The UnifiedGenotyper module in GATK was used to
produce the primary SNV calls, which were filtered
using the parameter ‘-stand_call_conf 50.0’ and the Var-
iant Filtration module, ensuring a coverage depth > 10
x, mapping quality > 25.0 and strand bias < 0. SNVs in
the vicinity of indels were removed by means of the
IndelGenotyperV2 module. Further filtration was
achieved using the criterion that homozygous reference
loci have a non-reference read frequency of < 10%,
heterozygous SNVs have a non-reference read frequency
of ≥10% and <85%, and homozygous non-reference
SNVs have a non-reference read frequency of ≥ 85%.
Small indels were called using mpileup with ‘-ugf’ and
bcftools with ‘-bvcg’ in SAMtools; and the calls were fil-
tered using the script vcfutils.pl in SAMtools with
default settings. Structural variants were identified initi-
ally using BreakDancer version 1.1 [26] and refined
using Pindel version 0.20 [27]. Somatic SNVs were
defined as heterozygous loci present in the tumor gen-
ome that corresponded to homozygous loci in the con-
trol genome, and LOH SNVs were defined as
heterozygous loci present in the control genome that
corresponded to homozygous loci in the tumor genome.
Novel somatic SNVs were obtained by removing all
LOHs and those SNVs already reported in dbSNP132.
LOHs were identified by comparison between control
and glioma reads using ExomeCNV version 1.23.0 [28].
Additional material
Additional File 1: Distributions of SNVs and indels among different
genomic regions. Header: Control SNV = SNVs in control DNA relative
to reference human genome GRCh37. Glioma SNV = SNVs in glioma
DNA relative to reference human genome. Somatic SNV = SNVs between
control and glioma DNAs. Control Indel = indels in control DNA relative
to reference human genome. Glioma Indel = indels in glioma DNA
relative to reference human genome. Somatic Indel = indels between
control and glioma DNAs. LOH SNV = LOHs between control and glioma
DNAs.
Additional File 2: Distribution of SNVs among different classes of
nucleotidyl changes. X-axis shows six different classes of possible
nucleotidyl change in SNV, and Y-axis shows percentage of each class.
Columns represent SNVs in control DNA relative to reference human
genome (blue), in glioma DNA relative to reference human genome
(red), and between the paired control and glioma DNAs (green).
Additional File 3: Distribution of LOHs on different chromosomes.
LOH regions are indicated in red, Non-LOH regions in yellow and
unmapped regions in black, on horizon line in the diagram for each
chromosome. Grey dots represent frequencies of non-reference alleles,
found in either control or glioma SNVs that were not represented in the
reference human genome. X axis shows position along each
chromosome, and Y axis the non-reference allele frequency.
Additional File 4: Genic regions in potential SNV hotspots revealed
by AluScans. Header: Potential Hotspot = chromosomal location of each
potential SNV hotspot shown on Figure 6. SNV position = positions of
different genic SNVs in an indicated hotspot. Region = location of a
genic SNV in a particular gene shown in ‘Gene’ column. Gene = name of
gene in an indicated hotspot containing an SNV.
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